Adaptimmune Therapeutics plc (MUN:473A)
0.0270
0.00 (0.00%)
At close: Jan 30, 2026
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of €6.25 million as of January 30, 2026. Its market cap has decreased by -95.86% in one year.
Market Cap
6.25M
Enterprise Value
25.29M
Revenue
55.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.03
Market Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.08B to 6.25M, a decrease of -99.42%. That is a compound annual growth rate of -38.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 6.25M | 6.43% |
| Dec 31, 2025 | 5.87M | -95.59% |
| Dec 31, 2024 | 133.14M | -18.29% |
| Dec 29, 2023 | 162.94M | -27.20% |
| Dec 30, 2022 | 223.81M | -56.55% |
| Dec 31, 2021 | 515.06M | -24.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AS Latvijas Juras medicinas centrs | 6.76M |
| Aktienbrauerei Kaufbeuren Aktiengesellschaft | 6.64M |
| Navstone SE | 6.07M |
| GIEAG Immobilien AG | 5.86M |
| Oberstdorfer Bergbahn AG | 5.82M |
| Sektkellerei J.Oppmann AG | 4.50M |
| Beteiligungen im Baltikum AG | 4.00M |
| CPU Softwarehouse AG | 3.42M |